A Phase II Clinical Study to Evaluate HLX43 in Subjects With Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma

Clinical trial NCT06857279 · RECRUITING

Trial details

NCT number: NCT06857279
Sponsor: Shanghai Henlius Biotech
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Carcinoma of Head and/or Neck

Start date: 2025-04-22
Primary completion: 2027-12-30
Enrollment: 167

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.